0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Albendazole Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-21Y9079
Home | Market Reports
Global Albendazole Market Outlook 2022
BUY CHAPTERS

Global Albendazole Market Research Report 2026

Code: QYRE-Auto-21Y9079
Report
2026-02-27
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Albendazole Market Size

The global Albendazole market was valued at US$ 198 million in 2025 and is anticipated to reach US$ 332 million by 2032, at a CAGR of 7.8% from 2026 to 2032.

Albendazole Market

Albendazole Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Albendazole competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite"s absorption of glucose, leading to depletion of the body"s glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK"s albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
This report delivers a comprehensive overview of the global Albendazole market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Albendazole. The Albendazole market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Albendazole market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Albendazole manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Albendazole Market Report

Report Metric Details
Report Name Albendazole Market
Accounted market size in 2025 US$ 198 million
Forecasted market size in 2032 US$ 332 million
CAGR 7.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Tablet
  • Capsule
  • Other
by Application
  • Human
  • Veterinary
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd, Supharma Chem, Salius Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Albendazole manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Albendazole sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Albendazole Market growing?

Ans: The Albendazole Market witnessing a CAGR of 7.8% during the forecast period 2026-2032.

What is the Albendazole Market size in 2032?

Ans: The Albendazole Market size in 2032 will be US$ 332 million.

What is the Huazhong Pharmaceutical, Jiangsu Qihui share in Albendazole Market?

Ans: The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.

Who are the main players in the Albendazole Market report?

Ans: The main players in the Albendazole Market are GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd, Supharma Chem, Salius Pharma

What are the Application segmentation covered in the Albendazole Market report?

Ans: The Applications covered in the Albendazole Market report are Human, Veterinary

What are the Type segmentation covered in the Albendazole Market report?

Ans: The Types covered in the Albendazole Market report are Tablet, Capsule, Other

1 Albendazole Market Overview
1.1 Product Definition
1.2 Albendazole by Type
1.2.1 Global Albendazole Market Value by Type: 2025 vs 2032
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Albendazole by Application
1.3.1 Global Albendazole Market Value by Application: 2025 vs 2032
1.3.2 Human
1.3.3 Veterinary
1.4 Global Albendazole Market Size Estimates and Forecasts
1.4.1 Global Albendazole Revenue 2021–2032
1.4.2 Global Albendazole Sales 2021–2032
1.4.3 Global Albendazole Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Albendazole Market Competition by Manufacturers
2.1 Global Albendazole Sales Market Share by Manufacturers (2021–2026)
2.2 Global Albendazole Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Albendazole Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Albendazole, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Albendazole, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Albendazole, Product Types and Applications
2.7 Global Key Manufacturers of Albendazole, Date of Entry into the Industry
2.8 Global Albendazole Market Competitive Situation and Trends
2.8.1 Global Albendazole Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Albendazole Players Market Share by Revenue
2.8.3 Global Albendazole Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Albendazole Market Scenario by Region
3.1 Global Albendazole Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Albendazole Sales by Region: 2021–2032
3.2.1 Global Albendazole Sales by Region: 2021–2026
3.2.2 Global Albendazole Sales by Region: 2027–2032
3.3 Global Albendazole Revenue by Region: 2021–2032
3.3.1 Global Albendazole Revenue by Region: 2021–2026
3.3.2 Global Albendazole Revenue by Region: 2027–2032
3.4 North America Albendazole Market Facts & Figures by Country
3.4.1 North America Albendazole Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Albendazole Sales by Country (2021–2032)
3.4.3 North America Albendazole Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Albendazole Market Facts & Figures by Country
3.5.1 Europe Albendazole Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Albendazole Sales by Country (2021–2032)
3.5.3 Europe Albendazole Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Albendazole Market Facts & Figures by Region
3.6.1 Asia Pacific Albendazole Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Albendazole Sales by Region (2021–2032)
3.6.3 Asia Pacific Albendazole Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Albendazole Market Facts & Figures by Country
3.7.1 Latin America Albendazole Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Albendazole Sales by Country (2021–2032)
3.7.3 Latin America Albendazole Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Albendazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Albendazole Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Albendazole Sales by Country (2021–2032)
3.8.3 Middle East and Africa Albendazole Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Albendazole Sales by Type (2021–2032)
4.1.1 Global Albendazole Sales by Type (2021–2026)
4.1.2 Global Albendazole Sales by Type (2027–2032)
4.1.3 Global Albendazole Sales Market Share by Type (2021–2032)
4.2 Global Albendazole Revenue by Type (2021–2032)
4.2.1 Global Albendazole Revenue by Type (2021–2026)
4.2.2 Global Albendazole Revenue by Type (2027–2032)
4.2.3 Global Albendazole Revenue Market Share by Type (2021–2032)
4.3 Global Albendazole Price by Type (2021–2032)
5 Segment by Application
5.1 Global Albendazole Sales by Application (2021–2032)
5.1.1 Global Albendazole Sales by Application (2021–2026)
5.1.2 Global Albendazole Sales by Application (2027–2032)
5.1.3 Global Albendazole Sales Market Share by Application (2021–2032)
5.2 Global Albendazole Revenue by Application (2021–2032)
5.2.1 Global Albendazole Revenue by Application (2021–2026)
5.2.2 Global Albendazole Revenue by Application (2027–2032)
5.2.3 Global Albendazole Revenue Market Share by Application (2021–2032)
5.3 Global Albendazole Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GlaxoSmithKline Albendazole Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Huazhong Pharmaceutical
6.2.1 Huazhong Pharmaceutical Company Information
6.2.2 Huazhong Pharmaceutical Description and Business Overview
6.2.3 Huazhong Pharmaceutical Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Huazhong Pharmaceutical Albendazole Product Portfolio
6.2.5 Huazhong Pharmaceutical Recent Developments/Updates
6.3 Jiangsu Qihui
6.3.1 Jiangsu Qihui Company Information
6.3.2 Jiangsu Qihui Description and Business Overview
6.3.3 Jiangsu Qihui Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jiangsu Qihui Albendazole Product Portfolio
6.3.5 Jiangsu Qihui Recent Developments/Updates
6.4 Sequent Scientific
6.4.1 Sequent Scientific Company Information
6.4.2 Sequent Scientific Description and Business Overview
6.4.3 Sequent Scientific Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sequent Scientific Albendazole Product Portfolio
6.4.5 Sequent Scientific Recent Developments/Updates
6.5 K.A. Malle Pharmaceuticals
6.5.1 K.A. Malle Pharmaceuticals Company Information
6.5.2 K.A. Malle Pharmaceuticals Description and Business Overview
6.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 K.A. Malle Pharmaceuticals Albendazole Product Portfolio
6.5.5 K.A. Malle Pharmaceuticals Recent Developments/Updates
6.6 Lasa Supergenerics Limited
6.6.1 Lasa Supergenerics Limited Company Information
6.6.2 Lasa Supergenerics Limited Description and Business Overview
6.6.3 Lasa Supergenerics Limited Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Lasa Supergenerics Limited Albendazole Product Portfolio
6.6.5 Lasa Supergenerics Limited Recent Developments/Updates
6.7 Zhongjia Pharmaceutical
6.7.1 Zhongjia Pharmaceutical Company Information
6.7.2 Zhongjia Pharmaceutical Description and Business Overview
6.7.3 Zhongjia Pharmaceutical Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Zhongjia Pharmaceutical Albendazole Product Portfolio
6.7.5 Zhongjia Pharmaceutical Recent Developments/Updates
6.8 Fredun Pharmaceuticals Ltd
6.8.1 Fredun Pharmaceuticals Ltd Company Information
6.8.2 Fredun Pharmaceuticals Ltd Description and Business Overview
6.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Fredun Pharmaceuticals Ltd Albendazole Product Portfolio
6.8.5 Fredun Pharmaceuticals Ltd Recent Developments/Updates
6.9 Supharma Chem
6.9.1 Supharma Chem Company Information
6.9.2 Supharma Chem Description and Business Overview
6.9.3 Supharma Chem Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Supharma Chem Albendazole Product Portfolio
6.9.5 Supharma Chem Recent Developments/Updates
6.10 Salius Pharma
6.10.1 Salius Pharma Company Information
6.10.2 Salius Pharma Description and Business Overview
6.10.3 Salius Pharma Albendazole Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Salius Pharma Albendazole Product Portfolio
6.10.5 Salius Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Albendazole Industry Chain Analysis
7.2 Albendazole Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Albendazole Production Mode & Process Analysis
7.4 Albendazole Sales and Marketing
7.4.1 Albendazole Sales Channels
7.4.2 Albendazole Distributors
7.5 Albendazole Customer Analysis
8 Albendazole Market Dynamics
8.1 Albendazole Industry Trends
8.2 Albendazole Market Drivers
8.3 Albendazole Market Challenges
8.4 Albendazole Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Albendazole Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Albendazole Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Albendazole Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Albendazole Sales (K MT) of Key Manufacturers (2021–2026)
 Table 5. Global Albendazole Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Albendazole Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Albendazole Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Albendazole Average Price (USD/MT) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Albendazole, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Albendazole, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Albendazole, Product Types and Applications
 Table 12. Global Key Manufacturers of Albendazole, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Albendazole Companies by Tier (Tier 1, Tier 2, Tier 3), based on Albendazole Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Albendazole Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Albendazole Sales by Region (K MT), 2021–2026
 Table 18. Global Albendazole Sales Market Share by Region (2021–2026)
 Table 19. Global Albendazole Sales by Region (K MT), 2027–2032
 Table 20. Global Albendazole Sales Market Share by Region (2027–2032)
 Table 21. Global Albendazole Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Albendazole Revenue Market Share by Region (2021–2026)
 Table 23. Global Albendazole Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Albendazole Revenue Market Share by Region (2027–2032)
 Table 25. North America Albendazole Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Albendazole Sales by Country (K MT), 2021–2026
 Table 27. North America Albendazole Sales by Country (K MT), 2027–2032
 Table 28. North America Albendazole Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Albendazole Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Albendazole Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Albendazole Sales by Country (K MT), 2021–2026
 Table 32. Europe Albendazole Sales by Country (K MT), 2027–2032
 Table 33. Europe Albendazole Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Albendazole Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Albendazole Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Albendazole Sales by Region (K MT), 2021–2026
 Table 37. Asia Pacific Albendazole Sales by Region (K MT), 2027–2032
 Table 38. Asia Pacific Albendazole Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Albendazole Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Albendazole Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Albendazole Sales by Country (K MT), 2021–2026
 Table 42. Latin America Albendazole Sales by Country (K MT), 2027–2032
 Table 43. Latin America Albendazole Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Albendazole Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Albendazole Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Albendazole Sales by Country (K MT), 2021–2026
 Table 47. Middle East and Africa Albendazole Sales by Country (K MT), 2027–2032
 Table 48. Middle East and Africa Albendazole Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Albendazole Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Albendazole Sales (K MT) by Type (2021–2026)
 Table 51. Global Albendazole Sales (K MT) by Type (2027–2032)
 Table 52. Global Albendazole Sales Market Share by Type (2021–2026)
 Table 53. Global Albendazole Sales Market Share by Type (2027–2032)
 Table 54. Global Albendazole Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Albendazole Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Albendazole Revenue Market Share by Type (2021–2026)
 Table 57. Global Albendazole Revenue Market Share by Type (2027–2032)
 Table 58. Global Albendazole Price (USD/MT) by Type (2021–2026)
 Table 59. Global Albendazole Price (USD/MT) by Type (2027–2032)
 Table 60. Global Albendazole Sales (K MT) by Application (2021–2026)
 Table 61. Global Albendazole Sales (K MT) by Application (2027–2032)
 Table 62. Global Albendazole Sales Market Share by Application (2021–2026)
 Table 63. Global Albendazole Sales Market Share by Application (2027–2032)
 Table 64. Global Albendazole Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Albendazole Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Albendazole Revenue Market Share by Application (2021–2026)
 Table 67. Global Albendazole Revenue Market Share by Application (2027–2032)
 Table 68. Global Albendazole Price (USD/MT) by Application (2021–2026)
 Table 69. Global Albendazole Price (USD/MT) by Application (2027–2032)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 73. GlaxoSmithKline Albendazole Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Huazhong Pharmaceutical Company Information
 Table 76. Huazhong Pharmaceutical Description and Business Overview
 Table 77. Huazhong Pharmaceutical Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 78. Huazhong Pharmaceutical Albendazole Product
 Table 79. Huazhong Pharmaceutical Recent Developments/Updates
 Table 80. Jiangsu Qihui Company Information
 Table 81. Jiangsu Qihui Description and Business Overview
 Table 82. Jiangsu Qihui Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 83. Jiangsu Qihui Albendazole Product
 Table 84. Jiangsu Qihui Recent Developments/Updates
 Table 85. Sequent Scientific Company Information
 Table 86. Sequent Scientific Description and Business Overview
 Table 87. Sequent Scientific Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 88. Sequent Scientific Albendazole Product
 Table 89. Sequent Scientific Recent Developments/Updates
 Table 90. K.A. Malle Pharmaceuticals Company Information
 Table 91. K.A. Malle Pharmaceuticals Description and Business Overview
 Table 92. K.A. Malle Pharmaceuticals Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 93. K.A. Malle Pharmaceuticals Albendazole Product
 Table 94. K.A. Malle Pharmaceuticals Recent Developments/Updates
 Table 95. Lasa Supergenerics Limited Company Information
 Table 96. Lasa Supergenerics Limited Description and Business Overview
 Table 97. Lasa Supergenerics Limited Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 98. Lasa Supergenerics Limited Albendazole Product
 Table 99. Lasa Supergenerics Limited Recent Developments/Updates
 Table 100. Zhongjia Pharmaceutical Company Information
 Table 101. Zhongjia Pharmaceutical Description and Business Overview
 Table 102. Zhongjia Pharmaceutical Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 103. Zhongjia Pharmaceutical Albendazole Product
 Table 104. Zhongjia Pharmaceutical Recent Developments/Updates
 Table 105. Fredun Pharmaceuticals Ltd Company Information
 Table 106. Fredun Pharmaceuticals Ltd Description and Business Overview
 Table 107. Fredun Pharmaceuticals Ltd Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 108. Fredun Pharmaceuticals Ltd Albendazole Product
 Table 109. Fredun Pharmaceuticals Ltd Recent Developments/Updates
 Table 110. Supharma Chem Company Information
 Table 111. Supharma Chem Description and Business Overview
 Table 112. Supharma Chem Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 113. Supharma Chem Albendazole Product
 Table 114. Supharma Chem Recent Developments/Updates
 Table 115. Salius Pharma Company Information
 Table 116. Salius Pharma Description and Business Overview
 Table 117. Salius Pharma Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 118. Salius Pharma Albendazole Product
 Table 119. Salius Pharma Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Albendazole Distributors List
 Table 123. Albendazole Customers List
 Table 124. Albendazole Market Trends
 Table 125. Albendazole Market Drivers
 Table 126. Albendazole Market Challenges
 Table 127. Albendazole Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Albendazole
 Figure 2. Global Albendazole Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Albendazole Market Share by Type: 2025 & 2032
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Albendazole Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Albendazole Market Share by Application: 2025 & 2032
 Figure 9. Human
 Figure 10. Veterinary
 Figure 11. Global Albendazole Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Albendazole Market Size (US$ Million), 2021–2032
 Figure 13. Global Albendazole Sales (K MT), 2021–2032
 Figure 14. Global Albendazole Average Price (USD/MT), 2021–2032
 Figure 15. Albendazole Report Years Considered
 Figure 16. Albendazole Sales Share by Manufacturers in 2025
 Figure 17. Global Albendazole Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Albendazole Players: Market Share by Revenue in Albendazole in 2025
 Figure 19. Albendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Albendazole Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Albendazole Sales Market Share by Country (2021–2032)
 Figure 22. North America Albendazole Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Albendazole Sales Market Share by Country (2021–2032)
 Figure 26. Europe Albendazole Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Albendazole Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Albendazole Revenue Market Share by Region (2021–2032)
 Figure 34. China Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Albendazole Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Albendazole Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Albendazole Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Albendazole Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Albendazole Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Albendazole by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Albendazole by Type (2021–2032)
 Figure 55. Global Albendazole Price (USD/MT) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Albendazole by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Albendazole by Application (2021–2032)
 Figure 58. Global Albendazole Price (USD/MT) by Application (2021–2032)
 Figure 59. Albendazole Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India